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Ischemic preconditioning specifically restores
complexes I and II activities of the mitochondrial
respiratory chain in ischemic skeletal muscle
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Objective: Defective mitochondrial function has been reported in patients presenting with peripheral arterial disease,
suggesting it might be an important underlying mechanism responsible for increased morbidity and mortality. We therefore
determined the effects of prolonged ischemia on energetic skeletal muscle and investigated whether ischemic preconditioning
might improve impaired electron transport chain and oxidative phosphorylation in ischemic skeletal muscle.
Methods: Thirty rats were divided in three groups: the control group (sham, n  9) underwent 5 hours of general
anesthesia without any ischemia, the ischemia–reperfusion (IR) group (n  11) underwent 5 hours ischemia induced by
a rubber band tourniquet applied on the left root of the hind limb, and in the third group, preconditioning (PC group,
n  10) was performed just before IR and consisted of three cycles of 10 minutes of ischemia, followed by 10 minutes
reperfusion. Maximal oxidative capacities (Vmax) of the gastrocnemius muscle and complexes I, II, and IV of the
mitochondrial respiratory chain were determined using glutamate-malate (Vmax), succinate (Vs), and N, N, N,=N=-
tetramethyl-p-phenylenediamine dihydrochloride ascorbate as substrates.
Results: Physiologic characteristics were similar in the three groups. Ischemia reduced Vmax by 43% (4.5  0.4 vs 7.9  0.5
mol O2/(min · g dry weight), P< .01) and Vs by 55% (2.9 0.3 vs 6.3 0.4mol O2/min/g dry weight; P< .01) in the
IR and sham groups, respectively, and impairments of mitochondrial complexes I and II activities were evident. Of interest was
that preconditioning prevented ischemia-induced mitochondrial dysfunction. Both Vmax and Vs were significantly higher in
the PC rats than in IR rats (32% and 41%, respectively; P < .05), and were not different from sham values.
Conclusions: Ischemic preconditioning counteracted ischemia-induced impairments of mitochondrial complexes I and II.
These data support that ischemic preconditioning might be an interesting approach to reduce muscular injuries in the
setting of ischemic vascular diseases. ( J Vasc Surg 2007;46:541-7.)
Clinical Relevance: The results of our experimental study showing protective effects of ischemic preconditioning on
ischemia-induced damage to mitochondrial complexes I and II is likely to be pertinent in humans. Indeed, acute and
chronic ischemia has been shown to induce mitochondrial dysfunctions in human skeletal muscles. Furthermore,
consistent experimental data support that mitochondrial activity enhancement results in an enhanced exercise
capacity, suggesting that an improvement in skeletal muscle mitochondrial function secondary to ischemic precon-
ditioning might be clinically interesting in patients with peripheral artery disease. Ischemic preconditioning might
therefore be useful to protect muscle function in the setting of relatively long periods of ischemia as observed in
complex thoracoabdominal aortic reconstructions, or in cases of vascular trauma, with a problem of flap tissue
transfer as seen during reconstructive surgery. Overcoming the fact that ischemic preconditioning might sometimes
be difficult to directly apply on the vessels and territories concerned by the surgical procedure, remote ischemic
preconditioning might be a new therapeutic approach in patients with peripheral arterial disease and critical limb
ischemia.Prolonged acute ischemia of the limb leads to irrevers-
ible skeletal muscle injuries if arterial reperfusion does not
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doi:10.1016/j.jvs.2007.04.075occur within few hours. Restoration of the arterial circula-
tion, although essential to avoid oxygen-deprived cellular
necrosis, results in reperfusion-induced tissue injuries
through an inflammatory response, with the development
of oxidative stress and free radical formation.1-4 This is a
major issue, because skeletal muscles undergoing ischemia
and reperfusion are observed in many vascular diseases as
well as in complex minimally invasive surgical procedures
using laparoscopic or minilaparotomy techniques.5-7 Of
further importance is that muscular infarctionmight arise in
case of autogenous muscle flap transplantation during re-
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quets are used.8-10 These techniques could require in-
creased total vascular clamp time and distal ischemia.
The macroscopic aspect of cellular necrosis and the
relationship between the extent of muscular necrosis and
energy depletion with reduced adenosine triphosphate
(ATP) have been well described.11 Nevertheless, data on
the effects of ischemia on skeletal muscle mitochondrial
function are more sparse, even though mitochondria,
which convert nutrients into energy through cellular respi-
ration, are the principal energy sources of the cell.12 One
study showed reduced skeletal muscle oxidative capacity
after 5 hours of ischemia in isolated rat mitochondria.13
Defective mitochondrial function has also been reported in
patients presenting with peripheral arterial disease, suggest-
ing that an impaired electron transport chain and oxidative
phosphorylation might be an important underlying mech-
anism responsible for morbidity and mortality associated
with peripheral arterial disease.14,15 Supporting this asser-
tion, in addition to a decreased blood flow, exercise capac-
ity has been shown to be related to mitochondrial respira-
tion both in animals and in humans.16,17
Consequently, prevention of mitochondrial dysfunc-
tion in skeletal muscle appears to be clinically pertinent, and
ischemic preconditioning might be an interesting ap-
proach, especially in case of prolonged ischemia. A protec-
tive effect of ischemic preconditioning against ischemia-
induced damage of the skeletal muscle was first reported by
Pang et al.1,18 Indeed, they showed that ischemic precon-
ditioning was associated with higher muscle content of
high-energy phosphates and lower lactate accumulation
during sustained ischemia.1,18
Although the mechanisms involved remain under dis-
cussion, several data further support a beneficial effect of
ischemic preconditioning on skeletal muscle being sub-
jected to ischemia.10,19 To date, however, an eventual
beneficial effect of ischemic preconditioning on skeletal
muscle oxidative capacities, particularly investigating alter-
ations of mitochondrial respiratory chain complexes, still
needs to be determined. We therefore hypothesized that
acute ischemia might alter skeletal muscle mitochondrial
function by reducing the activity of complexes I and II.
Furthermore, we determined whether ischemic precondi-
tioningmight significantly protect energetic skeletal muscle
from ischemia-induced alterations.
METHODS
Animals. Thirty Male Wistar rats (weight, 250 to 350
grams) were housed in a neutral temperature environment
(22°  2°C) on a 12:12 hour photoperiod and were
provided food and water ad libitum. This investigation was
done in accordance with the Helsinki Accords for Humane
Treatment of Animals During Experimentation.
Surgical preparation. Rats were anesthetized with an
intraperitoneal injection of sodium pentobarbital (0.1 mL/
100 grams body weight) and tracheotomized with a 14-
gauge canula for mechanical ventilation (SAR 830/P Small
Animal Ventilator, CWE Inc, Ardmore, Pa) (ambient air,50 mL/min respiratory rate). For the rats undergoing hind
limb ischemia, the left carotid artery was cannulated with
nonheparinized tubes (polyethylene tube, 0.58 mm inter-
nal diameter lumen, 0.96 mm external diameter lumen,
FOLIOPLAST, Harvard Medical, France) for systemic
blood pressure determination. Each rat was placed on an
electric blanket to maintain the body temperature at 37°C,
which was monitored by a rectal probe throughout the
experiment (Homeothermic Blanket Control Unit, Har-
vard Apparatus, Holliston, Mass).
Study design. Thirty rats were divided in three
groups: the control group (sham, n  9) underwent 5
hours of general anesthesia and the surgical manipulation
similar to that in the two other groups, but hind limb
ischemia was not induced. The ischemia–reperfusion (IR)
group (n 11) underwent 5 hours of ischemia induced by
a rubber band tourniquet applied on the left root of the
hind limb, followed by reperfusion. The reperfusion period
was limited to 5 minutes after the 5 hours of ischemia
because the deleterious effects of reperfusion occur early
and reducing the total experimentation duration reduces
the confusing effects of systemic alterations on the param-
eters investigated. Preconditioning (PC group, n10) was
performed in the third group just before ischemia–reperfusion.
Preconditioning consisted in three cycles of 10 minutes of
ischemia, followed by 10minutes of reperfusion.
Tissue processing of skeletal muscles. Ischemic and
control white gastrocnemius muscles were excised and
cleaned of adipose and connective tissues. Muscles were
immediately used for the study of respiratory parameters.
Study of mitochondrial respiration. This technique
ensures determination of global mitochondrial function,
reflecting both the density as well as the functional proper-
ties of the skeletal musclemitochondria. Themitochondrial
respiration was studied in saponin-skinned fibers, as previ-
ously described,16,17,20 to keep mitochondria in their ar-
chitectural environment.
Briefly, fibers are separated under binocular microscope
in solution S at 4°C (see below). After dissection, fibers are
transferred into solution S containing 50 g/mL of sapo-
nin and incubated at 4°C under intense shaking during 30
minutes for complete permeabilization of the sarcolemma.
Permeabilized (skinned) fibers are then washed in solution
S for 10 minutes under intense shaking to completely
remove saponin. Before oxygraphic measurements, the fi-
bers are washed twice in the respiration solution R for 5
minutes to remove any trace amount of high-energy phos-
phates and are transferred in a 3-mL water-jacketed oxy-
graphic cell (Strathkelvin Instruments, Glasgow, Scotland)
equipped with a Clark electrode as previously described.20
Solutions R and S contained 2.77 mM calcium potas-
sium (CaK2) ethylene glycol tetraacetic acid (EGTA), 7.23
mM K2EGTA (100 nM free Ca
2), 6.56 mM magnesium
chloride (1mM free Mg2), 20 mM taurine, 0.5 mM
dithiothreitol, 50 mM K-methane sulfonate (160 mM
ionic strength), and 20mM imidazole (pH 7.1). Solution S
also contained 5.7 mM Na2ATP, and 15 mM creatine
phosphate, and solution R contained 5 mM glutamate, 2
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bovine serum. After the experiments, fibers were harvested
and dried for 15 minutes at 150°C, and respiration rates
were expressed as mol O2/(min · g dry weight).
Measurement of the maximal muscular oxidative
capacities. Schematic representation of the mitochondrial
respiratory chain with specific substrates and inhibitors and
schematic oxygraph traces of permeabilized gastrocnemius
myofibers are given in Fig 1, A and B. After the determi-
nation of the basal oxygen consumption (V0), the maximal
fiber respiration rates were measured at 22°C under con-
tinuous stirring in the presence of saturating amount of
adenosine diphosphate (ADP) as a phosphate acceptor
(Vmax). The acceptor control ratio was Vmax/V0, and rep-
resents the degree of coupling between oxidation and
phosphorylation.
Measurement of the respiratory chain complexes.
Fig 1. A, Schematic representation of the mitochondrial respira-
tory chain with specific substrates and inhibitors. CI, Complex I
(nicotinamide adenine dinucleotide [NADH]-coenzyme Q
[CoQ] reductase); CII, complex II (succinate-CoQ reductase);
CIII, complex III (CoQH2-c reductase); CIV, complex IV (cyto-
chrome c oxidase); Cytc, cytochrome c; TMPD, N,N,N,=N=-tetra-
methyl-p-phenylenediamine dihydrochloride; e, electron; H,
proton. B, Schematic oxygraph traces of permeabilized skeletal
myofibers showing measurements of the respiratory chain com-
plexes, using indicated substrates and inhibitor. Details of proto-
cols are described in Method session. ADP, Adenosine diphos-
phate.When Vmax was recorded, electron flow goes throughcomplexes I, III, and IV. Complex I was blocked with
amital (0.02 mM) 4 minutes after this Vmax measurement,
and then complex II was stimulated with succinate (25
m). Mitochondrial respiration in these conditions was
evaluated by complexes II, III, IV (Vsucci). After that, N,
N, N,= N=-tetramethyl-p-phenylenediamine dihydrochlo-
ride (TMPD, 0.5 mM) and ascorbate (0.5mM) were added
as an artificial electron donor to cytochrome c. In these
conditions, cytochrome c oxydase (complex IV) was stud-
ied as an isolated step of the respiratory chain.21,22
Statistical analysis. Results are expressed as means 
standard error of the mean. Comparisons between means
were performed by using a two-way analysis of variance,
taking into account the effect of ischemia and the effect of
preconditioning. Statistical significance required a value of
P  .05.
RESULTS
The physiologic characteristics of the rats are presented
in the Table and were similar in the three groups. The heart




Glutamate-malate substrate. We measured the max-
imal respiratory rates of mitochondria in gastrocnemius
muscle at saturating ADP concentration in the presence of
glutamate-malate substrates (Vmax), and the results are
reported in Fig 2. After 5 hours of ischemia, Vmax was
significantly decreased in the ischemic muscle compared
with the muscles of sham animals (–43%, 4.5  0.4 vs
7.9  0.5 mol O2/[min · g dry weight], respectively,
P .01). The acceptor control ratio (Vmax/V0), represent-
ing the degree of coupling between oxidation and phos-
phorylation, was not significantly altered in the ischemic
skeletal muscle because of a proportional decrease of both
Vmax and V0.
Succinate substrate. The mitochondrial respiration
evaluated with succinate (VS, complexes II, III, IV, Fig 3)
was significantly lower in ischemic gastrocnemius com-
pared with sham muscles (–55%, 2.9  0.3 vs 6.3  0.4
mol O2/[min · g dry weight], respectively, P  .01).
TMPD-ascorbate substrates. The mitochondrial
respiration evaluated with TMPD-ascorbate substrates
(VTMPD, complex IV, Fig 4), was similar in ischemic and
sham skeletal muscles (13.4  0.9 vs 14.7  0.9 mol
O2/[min · g dry weight], respectively).
Preconditioning effects on mitochondrial function
All three substrates. In the PC group, the Vmax of the
ischemic gastrocnemius muscle was well protected (6.7 
0.7 vs 7.9 0.5 mol O2/[min · g dry weight] in PC and
sham groups, respectively, P  0.18; Fig 2).
When we compared the gastrocnemius muscles of the
PC and IR groups, both Vmax and VS were significantly
higher in the PC rats than in the IR rats (32% and 41%
respectively, P .05), confirming the significant protecting
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ischemic muscles. The values for Vmax, Vs (4.8 0.6 mol
O2/[min · g dry weight]), acceptor control ratio (3.0 
0.5), and VTMPD (12.3  0.9 mol O2/[min · g dry
weight]) were not different in the PC group compared with
the values observed in the sham gastrocnemius muscles
(Figs 2, 3, and 4).
DISCUSSION
The results of the study demonstrate for the first time,
to our knowledge, that ischemia impaired specifically the
Fig 2. A, Mitochondrial respiratory rate (Vmax) and B, acceptor
control ratio (ACR) measured in permeabilized superficial gas-
trocnemius skeletal muscle after 5 hours of ischemia–reperfusion
(IR) without (IR group) or with preconditioning protocol (PC
group). SHAM, Nonischemic gastrocnemius muscle control. Re-
sults are expressed as means  standard error of the mean. **P 
.01 vs SHAM; §P  .05 vs IR group.
Table. Physiologic characteristics of the three groups
Variable* Sham group
Weight (g) 277.4  5.5
Temperature (°C) 36.7  0.1
Mean arterial blood pressure (mm Hg) —
IR, Ischemia–reperfusion; PC, preconditioning.
*Results are presented as means  standard error of the mean.mitochondrial respiratory chain at the level of complexes Iand II, leaving complex IV activity unmodified. More
important, ischemic preconditioning protected skeletal
muscle mitochondrial function from the deleterious effects
of 5 hours of ischemia.
Ischemia and skeletal muscle oxidative capacities.
As expected, baseline physiologic characteristics of the rats
(temperature, heart rate, and systemic blood pressure) and
the control gastrocnemius muscle Vmax were normal and
similar to the data previously reported in nonischemic
gastrocnemius muscle.23 The hemodynamic characteristics
of the three experimental groups also remained stable
throughout the study. Thus, although pentobarbital might
theoretically impair visceral blood flow and cardiovascular
parameters, the low dose of sodium pentobarbital used
should not have significant deleterious effects on the exper-
imental animals. Inhalational anesthetic agents, which are
easy to use both in animals and humans, could have been an
alternative, but their preconditioning properties might
have inferred with the results of this study.24-26
Ischemia and reperfusion have to be considered as a
whole entity, and the duration of ischemia is the forecast of
skeletal muscle salvage or loss. Belkin et al27 showed with a
Fig 3. Maximal mitochondrial respiration evaluated with succi-
nate (VS, complexes II, III, IV) measured in permeabilized super-
ficial gastrocnemius skeletal muscle after 5 hours of ischemia–
reperfusion (IR), without (IR group) or with preconditioning (P)
protocol (PC group). SHAM, nonischemic gastrocnemius muscle
control. Results are expressed as means  standard error of the
mean. *P  .01; vs SHAM; §P  .05 vs IR group.
IR group PC group P
344.4  14.8 349.2  15 .94
37.1  0.04 37.17  0.09 .36
124.1  2.8 130  3.3 .13spectrophotometric analysis that significant muscle injury
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more severe after 5 hours. From our preliminary experi-
mental data and knowing that hind limb skeletal muscle
could resist anoxia up to 3 hours and the importance of skin
collateral circulation in rats, we performed leg ischemia for
5 five hours by applying a tourniquet on the root of the
hind limb.
A previous work investigating skeletal muscle mito-
chondria response to ischemia showed impairments of iso-
lated mitochondria, suggesting impairments of skeletal
muscle oxidative capacity.13 Measurements of the mito-
chondrial function allows assessment of the functional met-
abolic impairments of skeletal muscle, and the respiratory
rate in skinned fibers is a unique way to measure this
functional oxidative capacity of skeletal muscle by measur-
ing oxygen consumption of the entire mitochondrial pop-
ulation within its cellular environment.
We found that 5 hours of ischemia, followed by 5
minutes reperfusion, significantly decreased the mitochon-
drial function in the glycolytic gastrocnemius muscle, a
muscle well mimicking the metabolic characteristics of
deconditioned human skeletal muscle.21 Further exploring
the functional activity of the different mitochondrial respi-
ratory complexes, we observed that complex I and II were
altered in the same manner, whereas complex IV (VTMPD)
appeared to be unaffected from ischemic alterations. Be-
cause complex I is the rate-limiting step of the respiratory
chain, we can conclude that the global impairment of the
mitochondrial function is essentially related to the large
decrease of complex I functional activity.
Ischemic preconditioning and skeletal muscle oxi-
dative capacities. First described in the heart,28 ischemic
preconditioning reduced ischemia-related damage in many
Fig 4. Maximal mitochondrial respiration evaluated with
N,N,N,=N=-tetramethyl-p-phenylenediamine dihydrochloride-ascor-
bate (VTMPD, complex IV) measured in permeabilized superficial
gastrocnemius skeletal muscle after 5 hours of ischemia–reperfusion
(IR), without (IR group) or with preconditioning (P) protocol (P
group). SHAM, nonischemic gastrocnemius muscle control group.
Results are expressed as means standard error of the mean.organs, including liver and intestinal tract.29 Thus, Murryet al28 demonstrated that preconditioning limited myocar-
dial infarction to 25% of that seen in the control group. The
hypothesis of a reduction of ATP depletion by the precon-
ditioning was advanced by these authors.28
Ischemic preconditioning also attenuates the effects of
hepatic ischemia–reperfusion injury in case of transplanta-
tion and major resection of the liver, probably through a
decrease in reactive oxygen species production that leads to
a preservation of the microcirculatory function and ATP
preservation.29 Studies have also documented precondi-
tioning-induced improvements of ischemic tolerance in
animal skeletal muscle by analyzing the size of infarction,
microcirculation, vascular dysfunction, and skeletal muscle
function.1,30-32
Pang at al1 demonstrated that acute ischemic precon-
ditioning protects against skeletal muscle infarction in the
pig, reducing the infarct size by 44% in latissimus dorsi
muscle and by 62% gracilis muscle. Preconditioning was
associated with a lower energy metabolism during the
ischemic period. Preconditioning can also attenuate the
capillary no-reflow induced by prolonged ischemia (4
hours) and reperfusion (30 minutes) in skeletal muscle.
Such beneficial effects might involve the activation of KATP
channels.30
Of importance is that the improvement in muscle func-
tion resulting from preconditioning has functional implica-
tions since Gürke et al32 demonstrated a significant
reduction of skeletal muscle fatigue and an increased
performance after preconditioning in rats undergoing hind
limb ischemia. In humans, ischemic preconditioning of the
forearm reduced endothelial dysfunction and neutrophil
activation.33 Forearm preconditioning also protected the
heart in the setting of cardiac surgery, suggesting that
remote preconditioning might be useful.34 To date, how-
ever, there are no data concerning the possible beneficial
effects of ischemic preconditioning on skeletal muscle oxi-
dative capacity.
In the present study, we demonstrated that ischemic
preconditioning protected the functional capacities of com-
plex I and II, and then maintained the overall mitochon-
drial function (Vmax) of skeletal muscle from ischemia–
reperfusion injuries. Thus, ischemic preconditioning might
be a useful therapeutic method to protect the energy pro-
duction capacity of skeletal muscle. Moreover, the fact that
ischemic preconditioning protects mitochondrial com-
plexes I and II has important implications. Indeed, func-
tional integrity and rapid and appropriate responses to
physiologic and pathophysiologic stimuli are required for
mitochondria to meet cellular energy demands. In addi-
tion, mitochondria participate in cellular Ca2 homeosta-
sis, signalling cascades, and can initiate cell death under
certain conditions.
Of importance is that the mitochondrial respiratory
chain is also one of themain sources of endogenous reactive
oxygen species. Indeed, the electron transport chain, which
is central to the oxidative production of ATP in cells, has
been shown to be important in oxidative stress injury and is
a major source of reactive oxygen species in cells.35,36
JOURNAL OF VASCULAR SURGERY
September 2007546 Thaveau et alParticularly, inhibition of mitochondrial complexes is
known to increase reactive oxygen species generation.37
One may thus speculate that the ability of ischemic precon-
ditioning to protect the mitochondria from impairment at
the level of complexes I and II might suggest that ischemic
preconditioning could reduce the mitochondrial formation
of reactive oxygen species in skeletal myocytes.
Clinical implications. The results of our experimental
study showing protective effects of ischemic precondition-
ing on ischemia-induced damage to mitochondrial com-
plexes I and II is likely to be pertinent in humans. Indeed,
acute and chronic ischemia have been shown to induce mito-
chondrial dysfunctions in human skeletal muscles.13-15,38
Consistent experimental data also support that mitochon-
drial activity enhancement results in an enhanced exercise
capacity,16,17 suggesting that an improvement in skeletal
muscle mitochondrial function secondary to ischemic pre-
conditioning might be clinically interesting in patients with
peripheral artery disease.
Ischemic preconditioning might therefore be useful to
protect muscle function in the setting of relatively long
periods of ischemia, as is observed during reconstructive
surgery with flap tissue transfer.8,10 Overcoming the fact
that ischemic preconditioning might sometimes be difficult
to directly apply on the vessels and territories concerned by
the surgical procedure, remote ischemic preconditioning
might be a new therapeutic approach in patients with
peripheral arterial disease and critical limb ischemia.
CONCLUSION
This study demonstrates that prolonged ischemia sig-
nificantly impaired the mitochondrial respiratory chain at
the level of complexes I and II in skeletal muscle and that
ischemic preconditioning prevented such impairments.
Our results show the implication of mitochondrial com-
plexes in the mechanisms of ischemic preconditioning pro-
tective effects and that ischemic preconditioning might be
an interesting approach to reduce muscular injuries in the
setting of chronic ischemia and complex vascular surgery
and muscles flaps procedures.
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Protection of tissues from ischemic tissue damage by short
periods of ischemia, termed ischemic preconditioning (IP), was
described more than 15 years ago. Despite many animal experi-
ments that suggest that IP can significantly improve tissue viability
after ischemia and thousands of citations in PubMed, it has yet to
become part of the standard of care in vascular, cardiac, plastic, or
transplant surgery, where tissues are predictably rendered ischemic
and reperfused.
This experimental study in rats demonstrates the protection of
specific mitochondrial enzyme complexes in muscles pretreated
with three 10-minute cycles of ischemia and 10 minutes of reper-
fusion before a 5-hour period of ischemia. The protection de-
scribed was measured 5 minutes after reperfusion. These data in
skeletal muscle further refines our knowledge with respect to the
biochemical pathways that mediate this protection. Key unan-
swered questions include: Does this protection persist hours to
days later? Can IP improve muscle function or limb salvage that is
clinically measurable? These answers are relevant to surgeons and
their patients.
Vascular surgical procedures frequently induce muscle isch-
emia during elective surgical reconstructions but the duration of
ischemia is relatively short and usually well tolerated; thus, precon-
ditioning is rarely required. However, the more challenging clini-
cal situations are those where acute profound limb/muscle isch-
emia develops secondary to embolus, trauma, or thrombosis. In
these settings, no opportunity for muscle preconditioning is pos-frequently develops in these clinical scenarios. The ability to em-
ploy IP may be limited in vascular surgery but may be most useful
in transfer of free muscle flaps.
An area where IP may have much greater application to
vascular surgery would be in cardiac protection induced by remote
muscle ischemia. A recently published clinical trial in children used
intermittent leg ischemia before cardiac surgery and demonstrated
reduced troponin I release, decreased inotropic support require-
ments, and reduced cytokine levels postoperatively.1 If induction
of brief periods of skeletal muscle ischemia before elective vascular
surgical procedures would provide cardiac protection, this would
be a tremendous advance because myocardial infarction and other
cardiac complications are the principal cause of morbidity and
mortality after vascular surgery.
This article has provided biochemical evidence of the pathways
protected by IP in skeletal muscle. Further research will continue
to refine the exact pathways involved; however, more study is
required to determine the longer-term effectiveness of IP and its
applicability to common clinical situations where it may have
considerable impact.
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